Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saverio Minucci

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
The EMBO Journal|May 15, 2002
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescenceEmma Langley, Mark Pearson, Mario Faretta, et al.
Epigenetics & Chromatin|August 9, 2014
PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samplesStefano Amatori, Marco Ballarini, Alice Faversani, et al.
Biochemical and Biophysical Research Communications|August 23, 2005
Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cellsRinat Eshel, Olga Ben-Zaken, Oded Vainas, et al.
The Journal of Biological Chemistry|December 3, 2003
The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasomeMirco Fanelli, Anna Fantozzi, Pasquale De Luca, et al.
Cancer Cell|June 24, 2022
Sex and cancer immunotherapy: Current understanding and challengesLaura Pala, Tommaso De Pas, Chiara Catania, et al.
The EMBO Journal|February 21, 2004
Impairment of p53 acetylation, stability and function by an oncogenic transcription factorAlessandra Insinga, Silvia Monestiroli, Simona Ronzoni, et al.
European Journal of Medicinal Chemistry|June 15, 2018
Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitorsSandra N Milik, Amal Kamal Abdel-Aziz, Deena S Lasheen, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Bioorganic & Medicinal Chemistry|January 16, 2022
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemiaEman M E Dokla, Amal Kamal Abdel-Aziz, Sandra N Milik, et al.
Cancer Treatment Reviews|July 6, 2015
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedsideChiara Alessandra Cella, Saverio Minucci, Francesca Spada, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
The EMBO Journal|May 15, 2002
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescenceEmma Langley, Mark Pearson, Mario Faretta, et al.
Epigenetics & Chromatin|August 9, 2014
PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samplesStefano Amatori, Marco Ballarini, Alice Faversani, et al.
Biochemical and Biophysical Research Communications|August 23, 2005
Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cellsRinat Eshel, Olga Ben-Zaken, Oded Vainas, et al.
The Journal of Biological Chemistry|December 3, 2003
The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasomeMirco Fanelli, Anna Fantozzi, Pasquale De Luca, et al.
Cancer Cell|June 24, 2022
Sex and cancer immunotherapy: Current understanding and challengesLaura Pala, Tommaso De Pas, Chiara Catania, et al.
The EMBO Journal|February 21, 2004
Impairment of p53 acetylation, stability and function by an oncogenic transcription factorAlessandra Insinga, Silvia Monestiroli, Simona Ronzoni, et al.
European Journal of Medicinal Chemistry|June 15, 2018
Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitorsSandra N Milik, Amal Kamal Abdel-Aziz, Deena S Lasheen, et al.
Cancer Research|May 8, 2007
Suppressive effects of statins on acute promyelocytic leukemia cellsAntonella Sassano, Efstratios Katsoulidis, Giovanni Antico, et al.
Bioorganic & Medicinal Chemistry|January 16, 2022
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemiaEman M E Dokla, Amal Kamal Abdel-Aziz, Sandra N Milik, et al.
Cancer Treatment Reviews|July 6, 2015
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedsideChiara Alessandra Cella, Saverio Minucci, Francesca Spada, et al.
Pageof 17